Gaush Meditech Future Growth
Future criteria checks 4/6
Gaush Meditech is forecasted to grow earnings and revenue by 70.7% and 17.6% per annum respectively. EPS is expected to grow by 77.2%. Return on equity is forecast to be 15.9% in 3 years.
Key information
70.7%
Earnings growth rate
77.2%
EPS growth rate
| Medical Equipment earnings growth | 32.0% |
| Revenue growth rate | 17.6% |
| Future return on equity | 15.9% |
| Analyst coverage | Low |
| Last updated | 28 Apr 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2,140 | 341 | N/A | N/A | 1 |
| 12/31/2024 | 1,797 | 281 | N/A | N/A | 1 |
| 12/31/2023 | 1,509 | 229 | N/A | N/A | 1 |
| 12/31/2019 | 1,107 | -37 | 167 | 171 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2407 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.8%).
Earnings vs Market: 2407 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2407 is expected to become profitable in the next 3 years.
Revenue vs Market: 2407's revenue (17.6% per year) is forecast to grow faster than the Hong Kong market (9% per year).
High Growth Revenue: 2407's revenue (17.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2407's Return on Equity is forecast to be low in 3 years time (15.9%).